Prevalence of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Causing Bloodstream Infections in Cancer Patients from Southwest of Iran

References

• Garcia-Vidal C, Carratalà J, Gudiol C, et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2010;66(3):657–663. doi:10.1093/jac/dkq49421193475
   PubMed Web of Science ®Google Scholar
• Strojnik K, Mahkovic-Hergouth K, Novakovic BJ, Seruga B. Outcome of severe infections in afebrile neutropenic cancer patients. Radiol Oncol. 2016;50(4):442–448. doi:10.1515/raon-2016-001127904453
   PubMed Web of Science ®Google Scholar
• Obeng-Nkrumah N, Labi AK, Acquah ME, Donkor ES. Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting. BMC Res Notes. 2015;8(1):742. doi:10.1186/s13104-015-1701-z26628056
   PubMedGoogle Scholar
• Chandramohan L, Revell PA. Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population. Antimicrob Agents Chemother. 2012;56(9):4765–4770. doi:10.1128/AAC.00666-1222733062
   PubMed Web of Science ®Google Scholar
• Tohamy ST, Aboshanab KM, El-Mahallawy HA, El-Ansary MR, Afifi SS. Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations. Infect Drug Resist. 2018;11:791. doi:10.2147/IDR.S16329329872329
   PubMed Web of Science ®Google Scholar
• Bai L, Wang L, Yang X, et al. Prevalence and molecular characteristics of extended-spectrum β-lactamase genes in Escherichia coli isolated from diarrheic patients in China. Front Microbiol. 2017;8:144. doi:10.3389/fmicb.2017.0014428243225
   PubMed Web of Science ®Google Scholar
• Ur Rahman S, Ali T, Ali I, Khan NA, Han B, Gao J. The growing genetic and functional diversity of extended spectrum beta-lactamases. BioMed Res Int. 2018;2018.
   Web of Science ®Google Scholar
• Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev. 2018;31(2):e00079–17.29444952
   PubMed Web of Science ®Google Scholar
• Amin M, Sirous M, Javaherizadeh H, et al. Antibiotic resistance pattern and molecular characterization of extended-spectrum β-lactamase producing enteroaggregative Escherichia coli isolates in children from southwest Iran. Infect Drug Resist. 2018;11:1097-1104.
   Google Scholar
• CLSI. M100; Performance Standards for Antimicrobial Susceptibility Testing. 27th ed Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Kjerulf A, Hansen DS, Sandvang D, Hansen F, Frimodt-Moller N. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark. APMIS. 2008;116(2):118–124. doi:10.1111/j.1600-0463.2008.00777.x18321362
   PubMed Web of Science ®Google Scholar
• Sheikh AF, Moosavian M, Abdi M, et al. Prevalence and antimicrobial resistance of Shigella species isolated from diarrheal patients in Ahvaz, southwest Iran. Infect Drug Resist. 2019;12:249–253. doi:10.2147/IDR.S18786130774392
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56–e93.21258094
   PubMed Web of Science ®Google Scholar
• Marín M, Gudiol C, Ardanuy C, et al. Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection. Clin Microbiol Infect. 2015;21(6):583–590. doi:10.1016/j.cmi.2015.01.02925680311
   PubMed Web of Science ®Google Scholar
• Lubwama M, Phipps W, Najjuka CF, et al. Bacteremia in febrile cancer patients in Uganda. BMC Res Notes. 2019;12(1):464. doi:10.1186/s13104-019-4520-931362783
   PubMed Web of Science ®Google Scholar
• Gedik H, Yildirmak T, Simsek F, et al. The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies. Afr Health Sci. 2013;13(2):362–368. doi:10.4314/ahs.v13i2.2424235937
   PubMed Web of Science ®Google Scholar
• Gedik H, Şimşek F, Yıldırmak T, et al. Which multidrug-resitant bacteria are emerging in patients with hematological malignancies?: one-Year Report. Indian J Hematol Blood Transfus. 2015;31(1):51–56. doi:10.1007/s12288-014-0402-425548445
   PubMed Web of Science ®Google Scholar
• Khodashahi R, Hakemi-Vala M, Mardani M, et al. Blood culture and antimicrobial susceptibility pattern of bacteria and fungi isolated from febrile neutropenic patients treated with chemotherapy at Taleghani hospital, Tehran. Iran J Microbiol. 11;2:90–97.31341562
   PubMed Web of Science ®Google Scholar
• Meidani M, Bagheri A, Khorvash F. A population-based study of bacterial spectrum in febrile neutropenic patients. Jundishapur J Microbiol. 2013;6(2):150–156. doi:10.5812/jjm.4941
   Web of Science ®Google Scholar
• Carvalho AS, Lagana D, Catford J, Shaw D, Bak N. Bloodstream infections in neutropenic patients with haematological malignancies. Infect Dis Health. 2020;25(1):22–29. doi:10.1016/j.idh.2019.08.00631586572
   PubMed Web of Science ®Google Scholar
• Mangaraj O, Barkataki D, Mohan DG. Gram negative bacilli causing blood stream infection in febrile neutropenic patients in a tertiary care centre. Int J Contemp Med Res. 2017;4(7):1599–1603.
   Google Scholar
• Arega B, Woldeamanuel Y, Adane K, Sherif AA, Asrat D. Microbial spectrum and drug-resistance profile of isolates causing bloodstream infections in febrile cancer patients at a referral hospital in Addis Ababa, Ethiopia. Infect Drug Resist. 2018;11:1511–1519. doi:10.2147/IDR.S16886730271184
   PubMed Web of Science ®Google Scholar
• Rosa RG, Goldani LZ, Dos Santos RP. Risk factors for multidrug-resistant bacteremia in hospitalized cancer patients with febrile neutropenia: a cohort study. Am J Infect Contr. 2014;42(1):74–76. doi:10.1016/j.ajic.2013.06.025
   PubMed Web of Science ®Google Scholar
• Marin M, Gudiol C, Ardanuy C, et al. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours. J Infect. 2014;69(5):417–423. doi:10.1016/j.jinf.2014.05.01824960295
   PubMed Web of Science ®Google Scholar
• Islas-Muñoz B, Volkow-Fernández P, Ibanes-Gutiérrez C, Villamar-Ramírez A, Vilar-Compte D, Cornejo-Juárez P. Bloodstream infections in cancer patients. Risk factors associated with mortality. Int J Infect Dis. 2018;71:59–64. doi:10.1016/j.ijid.2018.03.02229649549
   PubMed Web of Science ®Google Scholar
• Gustinetti G, Mikulska M. Bloodstream infections in neutropenic cancer patients: a practical update. Virulence. 2016;7(3):280–297. doi:10.1080/21505594.2016.115682127002635
   PubMed Web of Science ®Google Scholar
• Babu KG, Lokanatha D, Lakshmaiah KC, et al. Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: a timeline of clinical and microbial trends through the years. Indian J Med Paediatr Oncol. 2016;37(3):174–182. doi:10.4103/0971-5851.19035227688611
   PubMedGoogle Scholar
• Seni J, Najjuka CF, Kateete DP, et al. Antimicrobial resistance in hospitalized surgical patients: a silently emerging public health concern in Uganda. BMC Res Notes. 2013;6(1):298. doi:10.1186/1756-0500-6-29823890206
   PubMedGoogle Scholar
• Ghosh I, Raina V, Kumar L, et al. Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India. Med Oncol. 2012;29(2):1354–1360. doi:10.1007/s12032-011-9858-321336987
   PubMed Web of Science ®Google Scholar
• Kim Y-J, Jung SM, Kang J, et al. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae infection causing septic shock in cancer patients with chemotherapy-induced febrile neutropenia. Intern Emerg Med. 2019;14(3):433–440. doi:10.1007/s11739-018-02015-x30600529
   PubMed Web of Science ®Google Scholar
• Alevizakos M, Gaitanidis A, Andreatos N, Arunachalam K, Flokas ME, Mylonakis E. Bloodstream infections due to ESBL-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents. 2017;50(5):657–663. doi:10.1016/j.ijantimicag.2017.07.00328705665
   PubMed Web of Science ®Google Scholar
• Zahedi Bialvaei A, Samadi Kafil H, Ebrahimzadeh Leylabadlo H, Asgharzadeh M, Aghazadeh M. Dissemination of carbapenemases producing Gram negative bacteria in the Middle East. Iran J Microbiol. 2015;7(5):226–246.26719779
   PubMedGoogle Scholar
• Zhang S, Wang Q, Ling Y, Hu X. Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer. BMC Cancer. 2015;15(1):42. doi:10.1186/s12885-015-1063-x25763661
   PubMed Web of Science ®Google Scholar
• Mirkalantari S, Masjedian F, Irajian G, Siddig EE, Fattahi A. Determination of the frequency of β-lactamase genes (blaSHV, blaTEM, blaCTX-M) and phylogenetic groups among ESBL-producing uropathogenic Escherichia coli isolated from outpatients. J Lab Med. 2020;44(1):27–33. doi:10.1515/labmed-2018-0136
   Google Scholar
• Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal colonization with extended-spectrum beta-lactamase–producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Rev Infect Dis. 2016;63(3):310–318. doi:10.1093/cid/ciw283
   Google Scholar
• Zhang Q, Gao HY, Li D, et al. Clinical outcome of Escherichia coli bloodstream infection in cancer patients with/without biofilm formation: a single-center retrospective study. Infect Drug Resist. 2019;12:359–371. doi:10.2147/IDR.S19207230809097
   PubMed Web of Science ®Google Scholar
• Yazdansetad S, Alkhudhairy MK, Najafpour R, et al. Preliminary survey of extended-spectrum β-lactamases (ESBLs) in nosocomial uropathogen Klebsiella pneumoniae in north-central Iran. Heliyon. 2019;5(9):e02349. doi:10.1016/j.heliyon.2019.e0234931687535
   PubMed Web of Science ®Google Scholar